
ABOUT AMETRIS
Founded in 2004, Ametris (formerly ActiGraph) is a global digital health solutions provider transforming real-world patient data into validated clinical evidence. Our end-to-end platform combines advanced wearables, regulatory-aligned analytics, and expert scientific support to simplify every phase of a clinical trial—from study design to submission. Backed by two decades of experience and a collaborative approach, Ametris empowers research teams to run smarter trials, reduce patient burden, and accelerate therapeutic innovation.
NEWS FEATURE
-
ActiGraph Is Rebranding As Ametris
ActiGraph has rebranded to Ametris to reflect its expanded data and technology platform, marking a new chapter in data-driven drug development and digital evidence generation.
DIGITAL ENDPOINTS LIBRARY
-
Explore how sensor-based digital health technologies can revolutionize the treatment and management of movement disorders by providing more accurate, patient-centered outcomes.
-
Find out how sensor-based digital health technologies (DHTs) offer direct, objective daily life assessments, accelerating NMD drug development.
-
Explore how digital health technologies can enhance obesity treatment by providing critical insights beyond weight loss.
-
Discover how recent advancements in wearable sensors and data science have provided the opportunities for objective and unobtrusive assessment of walking in the real world.
-
People with cancer emphasize quality of life (QOL) as an important health outcome across their journey. Explore how digital health technologies can collect patient-centric outcomes passively and remotely, minimizing the burden for people to participate in clinical trials.
-
Explore how an objective scratch measure is now achievable through the use of wrist-worn wearable technology that is both non-invasive and easy to implement.
-
Drug development in neurology is notoriously challenging. Despite being one of the most active areas of clinical development, neurological disease drug trials have among the longest development timelines and highest failure rates in the industry. Learn more in the available e-Book.
-
Wearable devices provide a low-burden and remote approach to quantifying people’s sleep. While difficult to estimate, learn how actigraphy is sensitive to treatment effects.
WEBINARS
CONTACT INFORMATION
Ametris (formerly ActiGraph)
70 N Baylen St, Suite 400
Pensacola, FL 32502
UNITED STATES
Phone: 850.332.7900
Contact: Genevieve Baley
SOLUTIONS
- A New Digital Health Solution For Long-Term Cough Monitoring
- Modernizing Clinical Research Through Digital Transformation
- Wearable Device Comparison Guide: Medical-Grade Or Consumer Device?
- Accelerate Clinical Development With Patient-Centered Digital Measures
- LEAP: A Multisensor Wearable For Patient-Centered Clinical Research
- CentrePoint: The Robust Digital Health Technology Platform
FEATURED ARTICLES
- Continuous Cough Monitoring: Addressing Placebo Effects And Data Gaps
- Wearables For Optical Cardiovascular Monitoring
- Deriving Reliable Clinical Outcome Scores From Continuous DHT Data
- Digital Measurement Of Nocturnal Scratch In Atopic Dermatitis
- Digital Outcome Measures Approved As Primary Endpoint In Cardiopulmonary Study
- Accelerate Respiratory Disease Trials: A Guide To Digital Endpoints
- A Guide To Digital Endpoints In Major Depressive Disorder
- Wearable DHT 10: Foundations, Regulations, And Real-World Applications
- Digital Health Solution For CRS Detection And Prediction
- Cytokine Release Syndrome Monitoring
- Different Stakeholder Perspectives On Navigating DHT Guidance
- Measuring Critical Health Outcomes Beyond Weight Loss In GLP-1 And Related Obesity Treatments
- Treatment Benefits Of Wearable DHTs For Patients With Cancer Cachexia
- Parkinson's Disease: Leveraging Wearable DHTs
- Real-World Value Realized From DHTs In Clinical Trials
- Demystifying AI: The Fundamentals And Applications In Drug Development
- Digital Endpoint Resource Guide: Parkinson's Disease
- Digital Measures To Advance Research And Quality Of Life In Schizophrenia
- Digital Endpoint Resource Guide: Obesity And Related Metabolic Disorders
- Wearable DHT 101: Foundations For Use In Regulated Clinical Trials